These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9700968)

  • 1. A combination of isradipine and naltrexone blocks cocaine's enhancement of a cocaine place preference.
    Cramer CM; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1998 Aug; 60(4):847-53. PubMed ID: 9700968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
    Cramer CM; Gardell LR; Boedeker KL; Harris JR; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):345-56. PubMed ID: 9632216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isradipine blocks cocaine's ability to facilitate pressing for intracranial stimulation.
    Gonzales PM; Boswell KJ; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1117-22. PubMed ID: 9408222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse.
    Reid LD; Pabello NG; Cramer CM; Hubbell CL
    Life Sci; 1997; 60(8):PL119-26. PubMed ID: 9042392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone.
    Pabello NG; Hubbell CL; Cavallaro CA; Barringer TM; Mendez JJ; Reid LD
    Pharmacol Biochem Behav; 1998 Oct; 61(2):181-92. PubMed ID: 9738534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of isradipine on cocaine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Mauldin JB
    J Clin Psychopharmacol; 2004 Apr; 24(2):180-91. PubMed ID: 15206666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isradipine produces neither a conditioned place preference nor aversion.
    Calcagnetti DJ; Schechter MD
    Life Sci; 1994; 54(6):PL81-6. PubMed ID: 8295483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics.
    Calcagnetti DJ; Keck BJ; Quatrella LA; Schechter MD
    Life Sci; 1995; 56(7):475-83. PubMed ID: 7869827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone and nalmefene attenuate cocaine place preference in male mice.
    Windisch KA; Reed B; Kreek MJ
    Neuropharmacology; 2018 Sep; 140():174-183. PubMed ID: 30048644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine.
    Reimer AR; Martin-Iverson MT
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):404-10. PubMed ID: 7862852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the naltrexone implant on rodent social interactions and cocaine-induced conditioned place preference.
    Mitchem LD; Kruschel CK; Dallman E; Anders KA; Czapiga M; Panos JJ; Steinpreis RE
    Pharmacol Biochem Behav; 1999 Jan; 62(1):97-102. PubMed ID: 9972851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats.
    Rademacher DJ; Steinpreis RE
    Neurosci Lett; 2002 Nov; 332(3):159-62. PubMed ID: 12399005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbiased cocaine conditioned place preferences (CPP) obscures conditioned locomotion, and nimodipine blockade of cocaine CPP is due to conditioned place aversions.
    Martin-Iverson MT; Reimer AR; Sharma S
    Psychopharmacology (Berl); 1997 Apr; 130(4):327-33. PubMed ID: 9160848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
    Leri F; Burns LH
    Pharmacol Biochem Behav; 2005 Oct; 82(2):252-62. PubMed ID: 16182352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine.
    Shippenberg TS; Heidbreder C
    Eur J Pharmacol; 1995 Jun; 280(1):55-61. PubMed ID: 7498254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine.
    Pani L; Kuzmin A; Martellotta MC; Gessa GL; Fratta W
    Brain Res Bull; 1991 Mar; 26(3):445-7. PubMed ID: 1828708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats.
    Martin-Iverson MT; Reimer AR
    Psychopharmacology (Berl); 1994 Mar; 114(2):315-20. PubMed ID: 7838925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine discrimination is attenuated by isradipine and CGS 10746B.
    Schechter MD
    Pharmacol Biochem Behav; 1993 Mar; 44(3):661-4. PubMed ID: 8095726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats.
    Martellotta MC; Kuzmin A; Muglia P; Gessa GL; Fratta W
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):378-80. PubMed ID: 7862848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioidergic modulation of cocaine conditioned place preferences.
    Bilsky EJ; Montegut MJ; Delong CL; Reid LD
    Life Sci; 1992; 50(14):PL85-90. PubMed ID: 1552818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.